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Waiting time for hip fracture surgery: 
hospital variation, causes, and effects on 
postoperative mortality
DATA ON 37,708 OPERATIONS REPORTED TO THE NORWEGIAN HIP 
FRACTURE REGISTER FROM 2014 TO 2018
Aims
This study aimed to describe preoperative waiting times for surgery in hip fracture pa-
tients in Norway, and analyze factors affecting waiting time and potential negative conse-
quences of prolonged waiting time.
Methods
Overall, 37,708 hip fractures in the Norwegian Hip Fracture Register from January 2014 to 
December 2018 were linked with data in the Norwegian Patient Registry. Hospitals treat-
ing hip fractures were characterized according to their hip fracture care. Waiting time 
(hours from admission to start of surgery), surgery within regular working hours, and sur-
gery on the day of or on the day after admission, i.e. ‘expedited surgery’ were estimated.
Results
Mean waiting time was 22.6 hours (SD 20.7); 36,652 patients (97.2%) waited less than 
three days (< 72 hours), and 27,527 of the patients (73%) were operated within regu-
lar working hours (08:00 to 16:00). Expedited surgery was given to 31,675 of patients 
(84%), and of these, 19,985 (53%) were treated during regular working hours. Patients 
classified as American Society of Anesthesiologists (ASA) classes 4 and 5 were more likely 
to have surgery within regular working hours (odds ratio (OR) 1.59; p < 0.001), and less 
likely to receive expedited surgery than ASA 1 patients (OR 0.29; p < 0.001). Low- volume 
hospitals treated a larger proportion of patients during regular working hours than high 
volume hospitals (OR 1.26; p < 0.001). High- volume hospitals had less expedited surgery 
and significantly longer waiting times than low and intermediate- low volume hospitals. 
Higher ASA classes and Charlson Comorbidity Index increased waiting time. Patients not 
receiving expedited surgery had higher 30- day and one- year mortality rates (OR 1.19; p < 
0.001) and OR 1.13; p < 0.001), respectively.
Conclusion
There is inequality in waiting time for hip fracture treatment in Norway. Variations in 
waiting time from admission to hip fracture surgery depended on both patient and hos-
pital factors. Not receiving expedited surgery was associated with increased 30- day and 
one- year mortality rates.
Cite this article: Bone Jt Open 2021;2-9:710–720.
Keywords: Orthogeriatrics, Hip fracture, Trauma, Health services
Introduction
A hip fracture in elderly people is associated 
with a substantially increased risk of death 
compared to the general population, and with 
subsequent 30- day mortality of around 8%.1 
Prolonged waiting time from fracture to surgery 
increases mortality.2,3 On the other hand, acelle-
rated surgery within six hours of diagnosis did 
not reduce postoperative mortality.4 Pincus et 
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al2 identified a potential threshold for defining higher risk 
related to waiting time at 24 hours.
Evidence- based guidelines from the National Insti-
tute of Health and Care Excellence (NICE) and the Amer-
ican Academy of Orthopaedic Surgeons recommend the 
shortest possible waiting time,5,6 and advocate performing 
surgery within 36 and 48 hours of admission, respectively. 
The Norwegian multidisciplinary guidelines (2018) concur 
with this view and recommend surgery preferably within 
24 hours, or at least within 48 hours after admission.7 The 
National Hip Fracture Database (NHFD) in the UK reports 
“prompt surgery”, defined as surgery on the day of or after 
admission, as a key performace indicator (KPI) in order to 
standardize and improve patient care.8
This study aimed to describe the temporal distribution 
of preoperative waiting time for surgery in patients with 
a hip fracture in Norway, particularly the proportion of 
patients receiving treatment within and outside regular 
working hours (08:00 to 16:00), receiving treatment 
within recommended waiting time, and having prompt 
(expedited) surgery. Further, we analyzed patient- 
and system- related factors affecting waiting time, and 
assessed potential effects on mortality of extended 
waiting time for surgery.
Methods
This is a national (5.3 million inhabitants in 2018) retro-
spective analysis of prospective data, based on linked 
data from the Norwegian Hip Fracture Register (NHFR) 
and the Norwegian Patient Registry (NPR). Patients’ 
unique national identification number enables precise 
coupling of data from these two registries.
National Hip Fracture Register. The NHFR has collected 
data on all hip fracture patients operated in Norwegian 
hospitals since 2005.9 Total hip arthroplasty (THA) as pri-
mary treatment is recorded in the Norwegian Arthroplasty 
Register and subsequently imported to the NHFR. Data 
from the NHFR were used to identify patients, and for re-
trieval of basic information on sex, age, American Society 
of Anesthesiologists (ASA) class, hospital identification, 
fracture type, type of operation, and grouping on sur-
geon experience (i.e. more than three years’ experience 
of fracture surgery). Completeness of reporting to the 
NHFR is evaluated regularly, and was 88.2% for osteosyn-
thesis, 94.5% for hemiarthroplasties, and 87.8% for THAs 
from 2015 to 2016.10 Date of death was retrieved from the 
National Population Register.
Characterization of hospitals. All 43 hospitals treating hip 
fractures in Norway were included. Hospital characteris-
tics and organization of hip fracture care (separate ward, 
dedicated hip fracture unit, hip fracture programme or 
orthogeriatric service) were obtained from a national sur-
vey of hospitals as part of this research programme.11 The 
hospitals were grouped in quartiles by hip fracture sur-
gery volume in the inclusion period.
Fig. 1
Flow chart patient selection Hip fractures recorded in the National Hip Fracture Register from 2014 to 2018.
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Administrative data. Administrative data from all hospi-
tals and other specialist healthcare providers are report-
ed to the NPR monthly including dates and exact times 
for admission, discharge and surgical interventions. 
Furthermore, data on all in- and outpatient contacts, in-
cluding ICD-10 diagnoses,12 from 1 January 2013 to 31 
December 2019 were obtained.
Comorbidity using the Charlson Comorbidity Index 
(CCI) was calculated from NPR data.13 The CCI has been 
validated for use in Norway.14
Waiting time in hours from admission to start of 
surgery was calculated. In addition, we categorized 
waiting time according to the UK NHFD definition, i.e., 
surgery on the day of or after admission, in this paper 
expressed as expedited surgery. The number of days 
waiting for surgery was calculated as the difference 
between the dates of surgery and admission and is given 
as day 0 (admission day), 1 or 2, and from day three 
onwards as day 3+. Time of surgery was further catego-
rized as daytime surgery (within regular working hours), 
afternoon/evening surgery (after regular working hours 
with reduced surgical capasity; 16:00 to 24:00), and 
night surgery (normally reserved for emergency surgery 
only; 00:00 to 08:00).
To explore the effect of delaying surgery from the 
afternoon and night the day after admission (day 1) to 
daytime on the following day (day 2), we defined two 
patient groups: one group operated between 16:00 (day 
1) and to 08:00 (day 2). The second group was operated 
on the following day (day 2) in daytime (08:00 to 16:00).
By 31 December 2019, the NHFR had compiled data 
on 41,699 fractures, admitted from 1 January 2014 to 31 
December 2018 (Figure  1). Patients with missing infor-
mation at time of admission or operation (n = 2,790; 
6.7%), and patients with pathological fracture (n = 405; 
1.0%), missing information on ASA class (n = 435; 1.0%), 
and combined fracture types or missing information on 
fracture type (n = 361; 0.9%) were excluded, leaving 
37,708 (90.4%) fractures for analyses (Figure  1), made 
up of 25,586 females (67.9%) and 12,122 males (32.1%), 
with a median age of 83 years (interquartile range (IQR) 
76 to 90). In analysis of mortality, patients suffering from 
a contralateral hip fracture within the observation time 
(minimum one year) were excluded (n = 938/37,708). 
Baseline patient characteristics are given in Table  I and 
hospital and system characteristics are presented in 
Table II.
Table I. Baseline patient characteristics.
Variable Data




Median age, yrs (IQR) 83 (76 to 90)
Females 84 (78 to 91)
Males 80 (72 to 89)




4 and 5 2,847 (7.5)
Charlson Comorbidity Index, n (%)
0 26,027 (69.0)
1 to 2 8,309 (22.0)
3 to 4 2,160 (5.7)
5 1,212 (3.2)
Fracture type, n (%)
Undisplaced femoral neck fracture - garden 1 to 2 4,877 (12.9)
Displaced femoral neck fracture - garden 3 to 4 17,293 (45.9)
Basocervical 1,070 (2.8)
Trochanteric AO/OTA A1 5,664 (15.0)
Trochanteric AO/OTA A2 5,919 (15.7)
Intertrochanteric AO/OTA A3 905 (2.4)
Subtrochanteric 1,980 (5.4)
Treatment type, n (%)
Two or three parallel screws 5,367 (14.2)
Arthroplasty 16,725 (44.4)
Sliding hip screw 8,471 (22.5)
Intramedullary nailing 6,656 (17.7)
Other 489 (1.3)
AO, Arbeitsgemeinschaft für osteosynthesefragen; ASA, American Society 
of Anaesthesiologists; IQR, interquartile range; OTA, Orthopaedic Trauma 
Association.
Table II. Hospital and structural characteristics for 37,708 hip fracture 
patients.
Variable n = 37,708, n (%)
Surgeons’ experience in fracture surgery
< 3 years 5,145 (13.6)
> 3 years 29,584 (78.5)
Missing 2,979 (7.9)
Hospital volume groups
Quartile 4 (range 1,128 to 2,639)* 18,006 (47.8)
Quartile 3 (range 746 to 1,124)* 10,074 (26.7)
Quartile 2 (range 524 to 740)* 6,913 (18.3)














*Range in hospital volume groups is total volume 2014 to 2018 for 
hospitals in quartile.
AO, Arbeitsgemeinschaft für osteosynthesefragen; OTA, Orthopaedic 
Trauma Association.
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Statistical analysis. The analyses were performed us-
ing SAS/STAT for Windows v. 8.2 (SAS Institute, USA). 
Continuous variables are presented as medians and IQRs. 
Categorical variables are presented as absolute numbers 
and percentages. Differences between categorical var-
iables were analyzed using multiple logistic regression, 
adjusted for sex, age, and ASA class, unless stated oth-
erwise. Age- dependent risk of death at 30 days and 365 
days after surgery was estimated by logistic regression 
analysis. Comparison between groups and differences in 
means of waiting time before surgery was evaluated by 
analysis of variance (ANOVA) with Bonferroni corrections, 
Fig. 2
Time of admission a) and time of surgery and b) for 37,708 patients.
Fig. 3
Temporal distribution of time of surgery after admission. Red boxes give normal working hours (08:00 to 16:00).
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and the corrections were justified due to the non- normal 
distribution of the observations. Association between vol-
ume and proportion treated expedited was evaluated by 
a linear regression model. Significance was set at 5% in 
all analyses.
Ethics, funding, and conflict of interest. The project was 
approved by the Northern Norway Regional Committee 
for Medical and Health Research Ethics and was exempted 
from the duty of confidentiality (REK 2018/1955). A data 
protection integrity assessment was compiled according 






(95% CI) p- value* Expedited surgery
Logistic regression, 
OR (95% CI) p- value*
Surgeon’s experience in fracture surgery   
> 3 years 29,584 15,565 (52.6) Ref 24,967 (84.4) Ref Ref
< 3 years 5,145 2,240 (43.5) 0.70 (0.66 to 0.74) < 0.001 4,447 (86.4) 1.11 (1.04 to 1.19) = 0.003
Missing 2,979 N/A   N/A N/A N/A N/A N/A
Hospital volume groups   
High volume (quartile 4) 18.006 9,712 (53.9) Ref Ref 14,570 (80.9%) Ref Ref
Intermediate- high volume (quartile 3) 10,074 4,925 (48.9%) 0.81 (0.78 to 0.86) < 0.001 8,591 (85.3%) 1.39 (1.30 to 1.49) < 0.001
Intermediate- low volume (quartile 2) 6,913 3,555 (51.4) 0.90 (0.85 to 0.95) < 0.001 6,180 (89.4) 2.05 (1.88 to 2.23) < 0.001
Low volume (quartile 1) 2,715 1,618 (59.6) 1.26 (1.16 to 1.37) < 0.001 2,402 (88.5) 1.83 (1.62 to 2.07) < 0.001
Orthogeriatric service   
Yes 16,631 8,820 (53.0) Ref Ref 13,940 (83.3) Ref Ref
No 21,077 10,990 (52.1) 0.97 (0.93 to 1.01) = 0.110 17,803 (84.5) 1.04 (0.96 to 1.10) = 0.157
Hip fracture programme   
Yes 34,978 18,320 (52.4) Ref Ref 29,273 (83.7) Ref Ref
No 2,730 1,490 (54.6) 1.10 (1-02 to 1.19) = 0.020 2,470 (90.5) 1.84 (1.62 to 2.10) < 0.001
Dedicated hip fracture unit   
Yes 15,296 8,441 (55.2) Ref Ref 12,562 (82.1) Ref Ref
No 22,412 11,369 (50.7) 0.84 (0.80 to 0.87) < 0.001 19,181 (85.6) 1.30 (1.23 to 1.38) < 0.001
Separate orthopaedic ward   
Yes 33,048 17,355 (52.5) Ref Ref 27,549 (83.4%) Ref Ref
No 4,660 2,455 (52.7) 1.01 (0.95 to 1.08) = 0.721 4,194 (90) 1.78 (1.61 to 1.96) < 0.001
*Logistic regression analyses were adjusted for sex, age, and American Society of Anesthesiologists class.
ASA, American Society of Anesthesiologists; CI, confidence interval; N/A, not applicable; OR, odds ratio.




Logistic regression, OR 
(95% CI) p- value*
Expedited surgery, 
n (%)
Logistic regression, OR 
(95% CI) p- value*
ASA class           
1 1,304 614 (47.1) Ref Ref 1,169 (89.7) Ref Ref
2 12,483 6,447 (51.6) 1.27 (1.13 to 1.43) < 0.001 10,946 (87.7) 0.71 (0.59 to 0.86) = 0.001
3 21,074 11,142 (52.9) 1.37 (1.21 to 1.54) < 0.001 17,485 (83.0) 0.47 (0.39 to 0.57) < 0.001
4 and 5 2,847 1,607 (56.4) 1.59 (1.38 to 1.83) < 0.001 2,143 (75.3) 0.29 (0.24 to 0.36) < 0.001
Charlson Comorbidity Index       
0 26,027 13,554 (52.1) Ref Ref 22,152 (85.1%) Ref Ref
1 to 2 8,309 4,456 (53.6) 1.07 (1.01 to 1.12) = 0.013 6,885 (82.9) 0.85 (0.80 to 0.91) < 0.001
3 to 4 2,160 1,152 (53.3) 1.05 (0.96 to 1.15) = 0.246 1,733 (80.2) 0.73 (0.65 to 0.81) < 0.001
5 1,212 648 (53.5) 1.06 (0.94 to 1.19) = 0.357 973 (80.3) 0.73 (0.63 to 0.84) < 0.001
Fracture type           
Displaced FNF - garden 3 to 4 17,293 10,036 (58.0) Ref Ref 14,175 (82.0) Ref Ref
Undisplaced FNF - garden 1 to 2 4,877 2,176 (44.6) 0.58 (0.55 to 0.62) < 0.001 4,148 (85.0) 1.21 (1.11 to 1.32) < 0.001
Basocervical 1,070 527 (49.3) 0.70 (0.62 to 0.79) < 0.001 929 (86.8) 1.49 (1.24 to 1.78) < 0.001
Trochanteric AO/OTA A1 5,664 2,686 (47.4) 0.65 (0.62 to 0.69) < 0.001 4,851 (85.7) 1.32 (1.21 to 1.43) < 0.001
Trochanteric AO/OTA A2 5,919 2,909 (49.2) 0.70 (0.66 to 0.74) < 0.001 5,098 (86.1) 1.37 (1.26 to 1.49) < 0.001
Intertrochanteric AO/OTA A3 905 437 (48.3) 0.67 (0.59 to 0.77) < 0.001 780 (86.2) 1.39 (1.15 to 1.69) < 0.001
Subtrochanteric 1,980 1,039 (52.5) 0.80 (0.72 to 0.88) < 0.001 1,762 (90.0) 1.78 (1.54 to 2.07) < 0.001
Treatment type     
Arthroplasty 16,725 9,757 (58.3) Ref Ref 13,629 (81.5) Ref Ref
2 or 3 parallel screws 5,367 2,418 (45.1) 0.58 (0.54 to 0.61) < 0.001 4,631 (86.3) 1.41 (1.29 to 1.55) < 0.001
Sliding hip screw 8,471 3,970 (46.9) 0.63 (0.60 to 0.66) < 0.001 7,247 (85.6) 1.35 (1.26 to 1.46) < 0.001
Intramedullary nailing 6,656 3,427 (51.5) 0.76 (0.72 to 0.80) < 0.001 5,809 (87.3) 1.57 (1.44 to 1.70) < 0.001
Other 489 238 (48.7) 0.67 (0.56 to 0.80) < 0.001 427 (87.3) 1.60 (1.22 to 2.10) < 0.001
*Logistic regression analyses adjusted for sex, age and ASA class, except analyses on American Society of Anesthesiologists and Charlson Comorbidity Index where American Society of Anesthesiologists class is excluded.
ASA, American Society of Anesthesiologists; CI, confidence interval; FNF, femoral neck fracture; OR, odds ratio; OTA, Orthopaedic Trauma Association.
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to the EU General Data Protection Regulation (GDPR). The 
project was funded by the Northern Norway Regional 
Health Authority (HNF1482-19). The NHFR is financed by 
the Western Norway Regional Health Authority. No com-
peting interests were declared.
Results
Time of admission and time of surgery. Admission time to 
hospital is illustrated in Figure 2a. Overall, 17,326 patients 
(46.0%) were admitted during daytime, 15,123 (40.1%) 
in the afternoon or evening, and 5,259 (14.0%) at night. 
Time for start of surgery on the day of operation, irre-
spective of waiting time, is shown in Figure  2b. In all, 
19,810 patients (52.5%) were operated during daytime, 
while 16,972 (45.0%) were operated on in the afternoon 
or evening. Night- time surgery was rarely performed (n 
= 926; 2.5%).
Distribution of time of surgery related to waiting 
time. The temporal distribution of time of surgery after 
admission is illustrated in Figure 3. A total of 12,103 of 
patients (32.1%) were operated on the day of admission 
(day 0), 19,640 (52.1%) the day after admission (day 1), 
4,901 (13.0%) on day 2, and 1,064 (2.8%) on day 3 or 
later (day 3+). An increasing proportion were operated 
during daytime and regular working hours for every day 
that passed: 3,042 (25%) on day 0, 12,424 (63%) on day 
1, and 3,568 (73%) on day 2 and day 3+. Overall, 288 pa-
tients (27%) operated on day 3+ had afternoon/evening 
or night surgery, and 243 surgeries (4%) took place at 
night- time from day 2 and onwards.
Patient-related factors and timing of surgery. High- risk 
patients (i.e. higher ASA class) were more often treated 
during daytime (Table  III). Displaced femoral neck frac-
tures (FNFs) were more likely to be treated during day-
time and within regular working hours than all other 
fracture types. Arthroplasties were also more frequently 
performed in daytime than other procedures (Table III).
Both higher ASA class and CCI score reduced the likeli-
hood of receiving expedited treatment (Table III). Subtro-
chanteric fractures were more likely to receive expedited 
surgery. Arthroplasties were less likely to receive expe-
dited surgery than all other surgical procedures.
Hospital/system factors and timing of surgery. Less ex-
perienced surgeons operated fewer patients in daytime 
and within regular working hours, but a higher pro-
portion within the period defined as expedited surgery 
Fig. 4
Scatter plot and linear regression displaying proportion of patients having expedited surgery related to hip fracture volume.
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(Table  IV). There was a significant trend that high vol-
ume hospitals had a lower proportion of patients treat-
ed with expedite surgery than low volume hospitals (r2 
= 0.1528; df = 41; mean square error 0.0048) (Figure 4).
An orthogeriatric service unit did not increase the 
proportion of patients having surgery within regular 
working hours or as expedited surgery. A dedicated 
hip fracture unit increased the proportion of patients 
having a daytime operation, but reduced the propor-
tion having expedited surgery. A separate orthopaedic 
ward reduced the proportion of patients having expe-
dited surgery (Table IV).
Differences in mean waiting time. Waiting time in-
creased significantly with higher ASA classes and in-
creasing CCI (Table V). Displaced FNFs treated with ar-
throplasty had statistically significantly longer waiting 
times than all other fractures and treatment types, ex-
cept basocervical fractures (Table V). High- volume (Q4) 
hospitals had significantly longer waiting times than 
low volume (Q1) and intermediate low- volume (Q2) 
hospitals. Low- volume (Q1) hospitals had almost five 
hours shorter waiting time (Table V).
Consequences of the timing of surgery. In unadjusted 
logistic regression analyses, non- expedited surgery 
resulted in higher 30- day and one- year mortality rates 
compared to expedited surgery (OR 1.19; 95% confi-
dence interval (CI) 1.08 to 1.31; p < 0.001, and OR 1.13; 
95% CI 1.06 to 1.20; p < 0.001, respectively). Working 
hours surgery on day 2 increased 30- day and one- 
year mortality compared to afternoon/evening/night 
surgery on day 1 in unadjusted analyses (Table  VI). 
Adjusting for age, sex, and ASA class resulted in insig-
nificant effects on mortality, whereas analyses adjusted 
for age, sex and CCI demonstrated that not receiving 
expedited surgery resulted in higher mortality rates. 
Figure  5 illustrates the effect on 30- day mortality for 
each ASA class and CCI group related to age. There was 
a statistically significant higher 30- day mortality rate for 
Table V. Differences in mean waiting time for surgery for specific groups analyzed with analysis of variance statistics.
Variable n (%) Mean 95% CI
p- values < 0.05 
marked by *
Mean total waiting time 37,708 22 h 36 m     
ASA class     
1 1,304 Ref   Ref   
2 12,483 3 h 21 m 1 h 40 m to 5 h2 m *
3 21,074 6 h 22 m 4 h 43 m to 8 h0 m *
4/5 2,847 12 h5 m 10 h 16 m to 13 h 53 m *
Charlson Comorbidity Index     
0 26,027 Ref   Ref   
Ref1 to 2 8,309 1 h20 m 38 m to 2 h1 m *
3 to 4 2,160 3 h35 m 2 h22 m to 4 h48 m *
5- 1,212 4 h3 7 m 3 h 1 m to 6 h 13 m *
Fracture type         
Displaced FNF - garden 3 to 4 17,293 Ref   Ref   
Undisplaced FNF - garden 1 to 2 4,877 - 1 h 56 m -2 h57 m to - 55 m *
Basocervical 1,070 - 1 h 40 m -3 h38 m to 19 m   
Trochanteric AO/OTA A1 5,664 - 2 h 21 m - 3 h 19 m to - 1 h 24 m *
Trochanteric AO/OTA A2 5,919 - 2 h 49 m - 3 h 46 m to - 1 h 53 m *
Intertrochanteric AO/OTA A3 905 - 2 h 34 min - 4 h 43 m to - 27 m *
Subtrochanteric 1,980 - 4 h 22 m - 5 h 52 m to - 2 h 53 m *
Treatment type     
Arthroplasty 16,725 Ref   Ref   
2/3 parallel screws 5,367 - 2 h 54 m - 3 h 48 m to - 1 h 59 m *
Sliding hip screw 8,471 - 2 h 22 m - 3 h 8 m to - 1 h 35 m *
Intramedullary nailing 6,656 - 3 h 49 m - 4 h 39 m to - 2 h 59 m *
Other 489 - 3 h 51 m - 6 h 31 m to - 1 h 12 m *
Hospital volume groups - increasing volume     
Quartile 4 18,006 Ref   Ref   
Quartile 3 10,074 10 m - 1 h 4 m to 1 h24 m   
Quartile 2 6,913 - 3 h 31 m - 4 h 42 m to - 2 h 21 m *
Quartile 1 2,715 - 4 h 54 m - 6 h 1 m to - 3 h 47 m *
The minus sign indicates a shorter waiting time than the reference value. In ANOVA analyses, the test show if variance is of such degree that the p- value is 
below a pre- set value -<0.05.
AO, Arbeitsgemeinschaft für osteosynthesefragen; CI, confidence interval; FNF, femoral neck fracture; IQR, interquartile range; OTA, Orthopaedic Trauma 
Association.; SD, standard deviation.
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non- expedited surgery than for expedited surgery in all 
CCI groups (OR 1.16; 95% CI 1.05 to 1.29; p = 0.004). 
All analyses were carried out by logistic regression, with 
adjustment stated in each analyses.
Discussion
The waiting time issue has been adressed using three 
indicators; waiting time in hours, surgery within regular 
working hours, and the UK KPI indicator expedited 
surgery (prompt surgery). Patient comorbidity, expressed 
as both higher ASA class and CCI score, increased waiting 
time. Similarly, fracture type and surgical procedure 
affected waiting time. Displaced FNF and treatment with 
arthroplasty prolonged waiting time, but at the same 
time increased the probability of surgery within regular 
working hours. We hypothesize that specialized surgeons 
performed the arthroplasties, especially THAs, in working 
hours. Other treatment alternatives may be considered 
less technically demanding, and require less surgical 
experience.
Compared to arthroplasties, other fracture treatments 
more frequently were performed outside regular working 
hours, and were more often performed by less experi-
enced surgeons.
The high- volume (Q4) hospital group had signifi-
cantly longer waiting times and a lower proportion of 
patients treated during regular working hours than Q1 
to Q3 volume groups. The larger hospitals should have 
resources and staff to perform surgery for a longer 
period of the day. Recently Nilsen et al15 demonstrated 
that strained hospital resources, increased waiting time 
to surgery by 20% and led to a 20% higher 60- day 
mortality. This supports our contention that hip fracture 
patients are not prioritized in hospital management.
Waiting time is a modifiable risk factor. Reimbursement 
schemes introduced to encourage expedited surgery 
have been followed by reduced preoperative waiting 
time.16 Introduction of the Best Practice Tariff (BPT) in 
the UK reduced preoperative waiting time and one- year 
mortality rate.17 Some hospitals have restructured fracture 
care for elderly people but with inconclusive effects.18–20 
The paradoxical effect on waiting time by system factors 
changes as demonstrated here, is a finding we cannot 
explain. Currently, there is no professional consensus 
nor high- level scientific evidence for the effectiveness of 
system changes. Despite the inconclusive scientific litera-
ture, optimalization of patient pathways with a focus on 
reducing unnecessary waiting should have high priority 
in day- to- day management.
Comorbidity was a factor in delayed surgery, but was 
also an independent predictor of postoperative mortality. 
Our interpretation is that the increased mortality we 
Table VI. The effect of expedite surgery and a subgroup analysis comparing surgery in the afternoon/night of day one with daytime surgery day two 30- 
day and one- year mortality.
Effect
Unadjusted, 
OR (95% CI) p- value*
                   Adjusted for
Age/sex, OR 
(95% CI) p- value*
Age/sex/ASA, 
OR (95% CI) p- value*
Age/sex/CCI, 
OR (95% CI) p- value*
Afternoon/night day 1 vs daytime 
day 2
      
30- day mortality
Expedite surgery       
Yes Ref Ref Ref Ref Ref Ref Ref Ref
No 1.19 (1.08 to 
1.31)
< 0.001 1.19 (1.08 to 
1.32)
= 0.001 0.99 (0.89 to 
1.10)
= 0.841 1.16 (1.05 to 
1.29)
= 0.004
Afternoon/night day 1 vs 
daytime day 2
  
    
Day 1 Ref Ref Ref Ref Ref Ref Ref Ref
Day 2 1.22 (1.05 to 
1.41)
= 0.008 1.26 (1.08 to 
1.46)
= 0.003 1.08 (0.93 to 
1.27)





Expedite surgery       
Yes Ref Ref Ref Ref Ref Ref Ref Ref
No 1.13 (1.06 to 
1.20)
< 0.001 1.14 (1.06 to 
1.22)
< 0.001 0.96 (0.89 to 
1.03)
= 0.243 1.10 (1.02 to 
1.17)
= 0.011
Day 1 Ref Ref Ref Ref Ref Ref Ref Ref
Day 2 1.10 (1.00 to 
1.21)
= 0.047 1.14 (1.03 to 
1.26)
= 0.010 1.01 (0.91 to 
1.12)
= 0.857 1.10 (1.00 to 
1.22)
= 0.057
*All analyses are logistic regressions. Adjustments stated in column heading.
ASA, American Society of Anesthesiologists; CCI, Charlson Comorbidity Index.; CI, confidence interval; OR, odds ratio.
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observed when waiting time was prolonged was 
explained by a delay in surgery for patients with greater 
comorbidity. Consequently, there is a balance between 
preoperative optimization of the patient and increasing 
waiting time.21 Waiting an extra night was associated 
with increased mortality in the postoperative period. 
An extra night may improve the fitness of patients with 
significant comorbidities but at the potential expense of 
a higher mortality, and increases patient’s discomfort by 
waiting immobilized.
In a narrative literature review, Lewis et al21 docu-
mented that ASA class was a consistent predictor of 
30- day mortality, while CCI expresses more underlying 
chronic diseases and pre- fracture function which also 
affects mortality. However, others have shown a low 
predictive power of comorbidity indicies for mortality 
after hip fractures treated with arthroplasty.22 Recently, 
Narula et al23 has shown, in a retrospective study, that 
the Clinical Frailty Scale (CFS) was a good predictor of 
mortality for hip fracture patients. CFS can not be esti-
mated based on routine administrative data but CFS data 
should be recorded in future prospective studies.
The increased postoperative death rate associated to 
treatment delay both in medically fit and unfit patients21 
are not substantial but in line with findings in other 
studies.2,3,24 A support for the notion that delay is asso-
ciated with increased mortality is the subgroup analysis 
comparing day 1/afternoon and evening surgery and 
surgery day two/working hours operations. Although the 
negative effect of treatment delay on mortality is relatively 
small, a more focused professional attention on delay as a 
health issue problem, could rectify this problem.
Both from a patient and health policy perspective, 
variations in waiting time for surgery is unwarranted 
healthcare inequality. Any contrast in hospital waiting 
time must be considered unwarranted. We conclude that 
expedited surgery, as used in the UK, is a better indicator 
than hours of waiting, embracing both the aspects of 
time and patient discomfort.
Strengths and limitations. The main strengths of the 
study are the large study population and the inclusion 
of all hospitals in Norway routinely treating hip fractures. 
We were not able to prove causality, although an asso-
ciation between mortality (or survival) and treatment 
delay has been documented. We acknowledge that pre- 
hospital waiting time was not included in our analysis. A 
previous study from the NHFR has shown that the medi-
an time from fracture to admission is six hours.3 Given a 
mean in- hospital waiting time of 23 hours in this study, 
we find it unlikely that the addition of pre- hospital wait-
ing time would have led to different results and changed 
our conclusions.
The findings in this study clearly indicate inequity in 
waiting time for hip fracture treatment in Norway. Vari-
ations in waiting time from admission to hip fracture 
surgery depended on both patient and hospital factors. 
Not receiving expedited treatment was associated with 
increased 30- day and one- year mortality rates. Further 
studies should address why such differences occur and 
Fig. 5
Mortality at 30 days postoperatively related to age of patients.
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whether specific patient groups should be prioritized 
differently.
Take home message
  - There is a substantial variation in waiting time for surgery 
after admission.
  - Both patient and hospital factors affect waiting time.
  - Prolonged waiting time for surgery increases 30- day and one- year 
mortality.
Twitter
Follow C. Kjaervik @doktorknokkel
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